Table 1.

Cell viability of human umbilical vein endothelial cells (HUVECs) treated by different concentrations of Ang II and blueberry anthocyanin (BBA) (n=5).

Concentrations of Ang II	Cell viability (OD/%)		Concentrations of BBA	Cell viability (OD/%)
	24 h	48 h		24 h	48 h
0 mol/L	1.11±0.03 (100%)	1.09±0.01 (100%)	0 μg/ml	1.15±0.02 (100%)	1.18±0.02 (100%)
10−9 mol/L	0. 98±0.02 (90%)*	0.98±0.01 (89%)*,#	2.5 μg/ml	1.23±0.04 (107%)*	1.23±0.04 (104%)*,#
10−8 mol/L	0.93±0.01 (84%)*	0.89±0.02 (81%)*,#	5.0 μg/ml	1.25±0.04 (109%)*	1.26±0.03 (106%)*,#
10−7 mol/L	0.84±0.02 (76%)*	0.80±0.02 (73%)*,#	10.0 μg/ml	1.27±0.01 (111%)*	1.32±0.03 (112%)*
10−6 mol/L	0.80±0.01 (73%)**	0.74±0.01 (68%)**,#	20.0 μg/ml	1.31±0.01 (114%)*	1.39±0.01 (117%)**,#
10−5 mol/L	0.71±0.03 (66%)**	0.66±0.03 (60%)**,#	40.0 μg/ml	1.22±0.01 (107%)*	1.19±0.04 (102%)*,#
10−4 mol/L	0.62±0.03 (56%)**	0.55±0.03 (50%)**,#	80.0 μg/ml	1.01±0.03 (89%)**	0.99±0.07 (84%)**,#

^{*, **}Represent significantly different at P<0.05 and P<0.01 when compared with HUVECs without treatment, respectively.

^#Represent significantly different at P<0.05 when compared with 24 h of treatment.